Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Investigational Drugs|August 23, 2013
Evaluation of the oral direct factor Xa inhibitor - betrixabanMichael Palladino, Geno Merli, Lynda Thomson
Journal of Thrombosis and Thrombolysis|February 18, 2011
New oral anticoagulantsTaki Galanis, Lynda Thomson, Michael Palladino, et al.
American Journal of Hematology|April 13, 2012
Implementing the new oral anticoagulants into the hospital formularyMichael Palladino, Lynda Thomson, Brian Swift, et al.
Cancer Research|October 22, 2009
Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitizationStavroula Baritaki, Kam Yeung, Michael Palladino, et al.
Journal of the National Medical Association|June 5, 2020
Rivaroxaban Versus Warfarin in African American Patients with Nonvalvular Atrial FibrillationCraig I Coleman, Stanley Thompson, Veronica Ashton, et al.
Molecular Cancer Therapeutics|August 8, 2006
The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemiaStacey Ruiz, Yelena Krupnik, Michael Keating, et al.
Disability and Rehabilitation|August 20, 2020
The diagnostic value of Red Flags in thoracolumbar pain: a systematic reviewFilippo Maselli, Michael Palladino, Valerio Barbari, et al.
Hospital Practice (1995)|December 16, 2014
Facilitating anticoagulation for safer transitions: preliminary outcomes from an emergency department deep vein thrombosis discharge programLaura Falconieri, Lynda Thomson, Glenn Oettinger, et al.
Thrombosis Journal|April 16, 2020
Rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism in African American patients: a retrospective cohort analysisOlivia S Costa, Stanley Thompson, Veronica Ashton, et al.
Blood|February 3, 2009
Caspase-8 dependent histone acetylation by a novel proteasome inhibitor, NPI-0052: a mechanism for synergy in leukemia cellsClaudia P Miller, Sharmistha Rudra, Michael J Keating, et al.
Pageof 2